Depyrogenated Sterile Empty Vials Market Report 2026

Depyrogenated Sterile Empty Vials Market Overview

• Depyrogenated Sterile Empty Vials market size has reached to $3.79 billion in 2025 • Expected to grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Surge In Infectious Diseases Drives Growth Of Depyrogenated Sterile Empty Vials Market • Market Trend: Advancements In Deep-Cold Sterile Vial Technology For Biopharmaceutical Applications • North America was the largest region in 2025.

What Is Covered Under Depyrogenated Sterile Empty Vials Market?

Depyrogenated sterile empty vials refer to borosilicate glass containers with butyl-rubber stoppers and aluminum seals used for injectable drug storage. Depyrogenation is referred to as the elimination of pyrogenic substances including bacterial endotoxins through the application of heat. The main product types of depyrogenated sterile empty vials are 2 ml, 5 ml, 10 ml, 20 ml, and >20 ml. 2 ML vial refers to the injectable drug container whose volume is 2 milliliters. ML refers to the volume of the container. The 2 ML vials are standard and large opening vials that are used with aluminum seals. The depyrogenated sterile empty vials are available in glass, and plastic packaging that are used by clinical labs, compounding labs, pharmaceutical companies, contract manufacturing organization, and distributors.

What Is The Depyrogenated Sterile Empty Vials Market Growth Forecast?

The depyrogenated sterile empty vials market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for biologics and biosimilars, rising investments in aseptic fill-finish facilities, expansion of contract manufacturing services, growing focus on contamination control, increasing adoption of pre-sterilized packaging. Major trends in the forecast period include increasing adoption of high-purity injectable packaging, rising demand for ready-to-fill vials, growing focus on endotoxin-free packaging standards, expansion of automated depyrogenation processes, enhanced emphasis on regulatory-compliant primary packaging.

Global Depyrogenated Sterile Empty Vials Market Segmentation

1) By Product: 2 ML, 5 ML, 10 ML, 20 ML, >20 ML 2) By Packaging: Glass, Plastic 3) By End User: Clinical Labs, Compounding Labs, Pharmaceutical Companies, Contract Manufacturing Organization, Distributors

What Is The Driver Of The Depyrogenated Sterile Empty Vials Market?

The increasing prevalence of infectious diseases across the globe is expected to propel the growth of the depyrogenated sterile empty vials market. Infectious diseases refer to conditions caused by harmful microorganisms such as bacteria, viruses, parasites, and fungi. Depyrogenated sterile vials are used for the storage of injectable medication involved in the treatment of infectious diseases. Additionally, depyrogenated sterile empty vials are also used for the collection of laboratory samples. For instance, in February 2024, according to the Health Security Agency, a UK-based government agency, cases of tuberculosis (TB) in England increased by 10.7% in 2023 compared to 2022. The number of cases rose from 4,380 in 2022 to 4,850 in 2023. Therefore, the increasing prevalence of infectious diseases across the globe will drive the growth of the depyrogenated sterile empty vials industry.

Key Players In The Global Depyrogenated Sterile Empty Vials Market

Major companies operating in the depyrogenated sterile empty vials market are APG Pharma, Corning Inc., DWK Life Sciences, Nipro PharmaPackaging, Schott AG, Thermo Fisher Scientific, Gerresheimer AG, Stevanato Group, SGD Pharma, Merck KGaA, SiO2 Materials Science, Shandong Pharmaceutical Glass Co. Ltd., West Pharmaceutical Services Inc., Ompi Srl, Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging Limited, Acme Vial and Glass Company LLC, Amposan S.A., BMT Corporation, Cangzhou Four Stars Glass Co. Ltd., Zhejiang Pharmaceutical-Packaging Co. Ltd.

Global Depyrogenated Sterile Empty Vials Market Trends and Insights

Major companies operating in the depyrogenated sterile empty vials market are focusing on developing innovative products, such as deep-cold freeze vials to meet the growing demand for safer, more reliable biopharmaceutical storage and transport. Deep-cold freeze vials are specialized sterile containers designed to safely store biological materials at extremely low temperatures (–80°C to –150°C). They help protect sensitive drugs, vaccines, and samples from degradation, maintain sterility, and ensure product stability during long-term storage and transport. For instance, in January 2024, SCHOTT Pharma AG & Co. KGaA, a Germany-based specialty glass manufacturing company, launched EVERIC freeze vials, an innovative vial family tailored for mRNA and gene-therapy products that require deep-cold storage and high container integrity. The EVERIC freeze vials are Type I borosilicate glass containers manufactured and qualified for use at ultralow temperatures; they combine strengthened glass geometry and process controls to limit breakage during freeze-thaw, are compatible with standard lyophilization and cryogenic logistics, offer controlled dimensional accuracy for automated filling and capping lines, and are intended to reduce delamination/particulate risks and improve drug stability compared with conventional vials, making them suitable for vaccines, gene-therapy vectors and other temperature-sensitive biologics.

What Are Latest Mergers And Acquisitions In The Depyrogenated Sterile Empty Vials Market?

In June 2023, ALK-Abelló, Inc., a Denmark-based pharmaceutical company that manufactures sterile empty vials, partnered with Galenova Inc. With this partnership, ALK-Abelló, Inc aims to provide reliable, high-quality glass vials to pharmacies and hospitals across Canada. Galenova Inc is a Canada-based company that provides pharmaceutical product, including depyrogenated sterile empty vials.

Regional Outlook

North America was the largest region in the depyrogenated sterile empty vials market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Depyrogenated Sterile Empty Vials Market?

The depyrogenated sterile empty vials market consists of sales of type I borosilicate glass, and molded and tabular glass depyrogenated sterile empty vials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.